Cline Darren S
- SEC CIK
- 0001633639
No open-market purchases or sales filed in the past year.
Current role at each company
- PLRX Pliant Therapeutics, Inc.Directoras of Jun 12, 2026
- PYXS Pyxis Oncology, Inc.Directoras of Mar 25, 2026
- XENE Xenon Pharmaceuticals Inc.Chief Commercial Officeras of Jan 9, 2026
- IMPL IPI Legacy Liquidation CoDirectoras of Jun 20, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Cline Darren S as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
PYXS Pyxis Oncology, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 (view filing) | Dec 8 | 1 day | Cline Darren SDirector | PPurchase | +10.0K | $9.39 | +$93.9K | New position10.0K after |